DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Metzger-Filho O, Viale G, Trippa L. et al.
HER2 heterogeneity as apredictor of response to neoadjuvant T-DM1 plus Pertuzumab: Results from a prospective clinical trial. ASCO 2019.

J Clin Oncol 2019;
37 (Suppl. 15) 502a

Download Bibliographical Data

Search in:
Access: